Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment.

Luca Mastorino,Paolo Dapavo,Sara Susca,Caterina Cariti,Niccolò Siliquini,Anna Verrone,Elena Stroppiana,Michela Ortoncelli,Pietro Quaglino,Simone Ribero

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG（2023）

引用 0|浏览3

暂无评分

摘要

IL-23 inhibitors showed the best performance on DS. Overall, the most effective class was IL-17 inhibitors considering the short-term effectiveness, but long-term effectiveness is in favor of anti-IL-23.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要